Manzo, Bb Boy 1 .
HRN: 22-18-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2022
AMPICILLIN 500MG (VIAL)
11/13/2022
11/20/2022
IVT
100mg
Q12
PSNB Sec To PROM; RDS
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes